Expression of IL-1β in supraspinal brain regions in rats with neuropathic pain
Section snippets
Acknowledgements
We thank M. Centeno, M. Baliki, P. Geha, and R. Jabakhanji for help in tissue processing and data analysis and E. Mugnaini for technical advice. The study was funded by NIH NINDS NS42660 and the DFG (RE 1451/2-2).
References (37)
- et al.
Changes in cerebrospinal fluid levels of pro-inflammatory cytokines in CRPS
Pain
(2005) - et al.
Chronic pain patients are impaired on an emotional decision-making task
Pain
(2004) - et al.
Attenuation of neuropathic manifestations by local block of the activities of the ventrolateral orbito-frontal area in the rat
Neuroscience
(2003) - et al.
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Pain
(1988) - et al.
Quantitative assessment of tactile allodynia in the rat paw
J. Neurosci. Methods
(1994) - et al.
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain
Pain
(2005) - et al.
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Anal. Biochem.
(1987) - et al.
The effect of site and type of nerve injury on spinal glial activation and neuropathic pain behavior
Exp. Neurol.
(1999) - et al.
Spared nerve injury: an animal model of persistent peripheral neuropathic pain
Pain
(2000) - et al.
Abnormal brain chemistry in chronic back pain: an in vivo proton magnetic resonance spectroscopy study
Pain
(2000)
Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation
Pain
(2005)
Influence of various experimental parameters on the incidence of thermal and mechanical hyperalgesia induced by a constriction mononeuropathy of the sciatic nerve in lightly anesthetized rats
Exp. Neurol.
(1994)
Possible chemical contribution from chromic gut sutures produces disorders of pain sensation like those seen in man
Pain
(1993)
Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats
Brain Res.
(1993)
Intracerebroventricular injection of interleukin-1 beta enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats
Brain Res.
(1994)
Contralateral non-operated nerve to transected rat sciatic nerve shows increased expression of IL-1beta, TGF-beta1, TNF-alpha, and IL-10
J. Neuroimmunol.
(2002)
Neutralizing antibodies to interleukin 1-receptor reduce pain associated behavior in mice with experimental neuropathy
Neurosci. Lett.
(1999)
Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain
Neuroscience
(2001)
Cited by (96)
Targeting G protein coupled receptors for alleviating neuropathic pain
2022, Progress in Molecular Biology and Translational ScienceMicroRNA and chronic pain: From mechanisms to therapeutic potential
2017, Pharmacology and TherapeuticsTargeting cytokines for treatment of neuropathic pain
2017, Scandinavian Journal of PainThe inflammasome as a target for pain therapy
2016, British Journal of AnaesthesiaCitation Excerpt :What signals are responsible for NALP1 activation? Finally, the observation that IL-1β expression is altered in the brainstem, hippocampus, thalamus, and prefrontal cortex after sciatic nerve injury66 or spinal nerve ligation67 suggests that future studies should be directed at understanding inflammasome activation in higher CNS regions. Central neuropathic pain is encountered in chronic neurodegenerative diseases, such as AD and MS, and in post-trauma states, such as spinal cord injury and traumatic brain injury.1
Copyright © 2006 Elsevier Ireland Ltd. All rights reserved.